Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Kantoff

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Current Problems in Cancer|September 1, 1990
Bladder cancerP W Kantoff
Seminars in Oncology|February 1, 1995
New agents in the therapy of hormone-refractory patients with prostate cancerP W Kantoff
Transactions of the American Academy of Insurance Medicine : Annual Meeting. American Academy of Insurance Medicine. Meeting|January 1, 1993
Prostate cancerP W Kantoff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer?J P Richie, P W Kantoff
The Urologic Clinics of North America|June 11, 1999
Prognostic indicators in hormone refractory prostate cancerD J George, P W Kantoff
Seminars in Oncology|December 1, 1995
Neoadjuvant and adjuvant chemotherapy for invasive bladder cancerM R Smith, P W Kantoff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
The radical prostatectomy series: apples are not orangesP W Kantoff, J A Talcott
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1988
Late toxicities, long-term follow-up, less intensive treatment: leading issues in the therapy of testis cancerP W Kantoff, M B Garnick
The Journal of Urology|September 29, 1998
Management of hormone refractory prostate cancer: current standards and future prospectsW K Oh, P W Kantoff
Hematology/Oncology Clinics of North America|February 1, 1992
Chemotherapy for metastatic bladder cancerP W Kantoff, H I Scher
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Current Problems in Cancer|September 1, 1990
Bladder cancerP W Kantoff
Seminars in Oncology|February 1, 1995
New agents in the therapy of hormone-refractory patients with prostate cancerP W Kantoff
Transactions of the American Academy of Insurance Medicine : Annual Meeting. American Academy of Insurance Medicine. Meeting|January 1, 1993
Prostate cancerP W Kantoff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer?J P Richie, P W Kantoff
The Urologic Clinics of North America|June 11, 1999
Prognostic indicators in hormone refractory prostate cancerD J George, P W Kantoff
Seminars in Oncology|December 1, 1995
Neoadjuvant and adjuvant chemotherapy for invasive bladder cancerM R Smith, P W Kantoff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
The radical prostatectomy series: apples are not orangesP W Kantoff, J A Talcott
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1988
Late toxicities, long-term follow-up, less intensive treatment: leading issues in the therapy of testis cancerP W Kantoff, M B Garnick
The Journal of Urology|September 29, 1998
Management of hormone refractory prostate cancer: current standards and future prospectsW K Oh, P W Kantoff
Hematology/Oncology Clinics of North America|February 1, 1992
Chemotherapy for metastatic bladder cancerP W Kantoff, H I Scher
Pageof 10